Medical Devices Startups

NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.

1 investor

Nanodropper makes an FDA-listed, sterile twist-on adaptor that attaches to eyedrop bottles to dispense smaller drops, reducing medication waste and extending bottle life. It serves patients using glaucoma, dry eye, cataract, and myopia eyedrops, as well as optometry and ophthalmology clinics.

1 investor

NanoDrops develops an add-on platform for presbyopia correction that works with existing refractive lasers to provide vision correction. The solution targets patients and doctors seeking adjustable, reversible approaches to address presbyopia without permanent modifications to the eye.

1 investor

Nanoe manufactures high-performance ceramic powders and composites, including alumina and zirconia, serving demanding industries such as biomedical and semiconductors. The company also produces Zetamix, a line of ceramic and metal filaments compatible with 3D printers.

1 investor

NANOEGG is a pharmaceutical and cosmetics development company that conducts drug research and development, produces non-pharmaceutical health products and cosmetics, and sells pharmaceutical bases and cosmetic raw materials. The company serves pharmaceutical manufacturers, cosmetics brands, and health product developers in Japan.

1 investor

Nanoflex Robotics develops a telerobotics intervention system using magnetic navigation and ultra-flexible microrobotic devices to let physicians perform endovascular procedures such as thrombectomies remotely, starting with acute ischemic stroke. The system aims to reduce patient transfer and waiting times for critical endovascular interventions regardless of location.</parameter> <parameter name="hq_city">Glattbrugg

1 investor

Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery. The patch is applied during surgery without extra tools and can serve as a local drug delivery system, targeting surgical care in Europe.

1 investor

A Canadian pharmacy compounding service that prepares customized medications in various dosage forms including capsules, tablets, gummies, creams, and veterinary treatments for patients and animals with specialized pharmaceutical needs.

1 investor

NanoGuard Technologies develops sterilization technologies for medical applications.

1 investor

NanoMedical Systems develops subcutaneous implantable drug-delivery devices built on its nStrada nanofluidics platform, which uses arrays of precision nanochannels to provide long-term, constant release of small molecules, peptides, and proteins for chronic therapies. The platform, manufactured with semiconductor methods, offers passive, refillable, and remotely controlled delivery systems for pharmaceutical and biologic drug delivery.

1 investor

Nanopath is developing a molecular diagnostic platform designed for point-of-care disease diagnosis, with a focus on women's health. The company works to commercialize novel diagnostic technologies aimed at improving human health.

1 investor

Oxford Nanopore offers educational programs and tools to make DNA sequencing accessible to students and educators from high school through undergraduate levels. The company works with institutions and scientific educators to integrate nanopore sequencing technology into classroom settings and address the world's pressing challenges.

1 investor

NanoProX develops bismuth sulfide (Bi₂S₃) nanoparticles administered intravenously before radiotherapy to selectively accumulate in tumors and amplify local radiation dose, aiming to increase tumor cell elimination per session without new equipment. The company targets oncology treatment and works with research institutions and clinical centers on preclinical and clinical translation.

1 investor

Nanoptima develops drug delivery technologies for ophthalmic applications, focusing on biomaterial-based solutions for retinal and eye diseases. The company draws on deep pharma and biotech expertise to advance formulation science and delivery mechanisms for pharmaceutical treatments.

1 investor

Nanordica Medical develops the Nanordica Advanced Antibacterial Wound Dressing, a sterile single-use dressing made of natural silk nanofibers with antibacterial nanoparticles (Premotiv technology) that prevents infection and promotes healing of chronic and infected wounds such as diabetic foot ulcers. The Estonian medtech company, a spin-off of the National Institute of Chemical Physics and Biophysics, serves wound-care and clinical settings.

1 investor

NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development. The company serves biotech and pharmaceutical customers working on therapeutics and medical treatments.

1 investor

NanoTess is a social enterprise developing catalytic materials to address wound care and skin health challenges, with a focus on making healthcare technologies accessible and affordable for patients and communities globally.

1 investor

Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.

1 investor

Nanovis develops and manufactures nanoscale surface technologies designed to improve the integration of orthopedic, spinal, and dental implants. It supplies these implant surface technologies to medical device makers and OEM partners in the medtech industry.

1 investor

NAPA is an anesthesia services provider that operates a network of clinical and corporate teams focused on patient care delivery and anesthesia management. The company serves healthcare facilities and operates with nearly 5,000 clinicians and support staff.

1 investor

The National Cancer Institute is the federal government's principal agency for cancer research and training, supporting a broad research portfolio to advance progress against cancer.

1 investor

Natus Sensory develops medical devices and solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems. The company serves healthcare providers and patients worldwide and maintains manufacturing sites across multiple countries with ISO and FDA certifications.

1 investor

NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.

1 investor

CMR Naviscan develops a breast imaging technology aimed at improving invasive cancer detection rates and reducing unnecessary biopsies, particularly in women with dense breast tissue. It positions its modality as a lower-cost alternative that addresses limitations of existing breast cancer screening methods.

1 investor